{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:35:16Z","timestamp":1790184916718,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02846-z","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T05:02:57Z","timestamp":1711429377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030"],"prefix":"10.1007","volume":"316","author":[{"given":"Kaijie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"issue":"9997","key":"2846_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W-H Boehncke","year":"2015","unstructured":"Boehncke W-H, Sch\u00f6n MP (2015) Psoriasis. Lancet 386(9997):983\u2013994. https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7","journal-title":"Lancet"},{"issue":"10281","key":"2846_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN (2021) Psoriasis. Lancet 397(10281):1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"2846_CR3","volume-title":"Global report on psoriasis","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Global report on psoriasis. World Health Organization, Geneva"},{"issue":"2","key":"2846_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 31(2):205\u2013212. https:\/\/doi.org\/10.1111\/jdv.13854","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2846_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11926-018-0753-1","volume":"20","author":"F Prignano","year":"2018","unstructured":"Prignano F, Rogai V, Cavallucci E, Bitossi A, Hammen V, Cantini F (2018) Epidemiology of psoriasis and psoriatic arthritis in Italy-a systematic review. Curr Rheumatol Rep 20(7):43. https:\/\/doi.org\/10.1007\/s11926-018-0753-1","journal-title":"Curr Rheumatol Rep"},{"key":"2846_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"2846_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094983","author":"RG Petit","year":"2021","unstructured":"Petit RG, Cano A, Ortiz A, Espina M, Prat J, Mu\u00f1oz M et al (2021) Psoriasis: from pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094983","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2846_CR8","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy MJ, Cua DJ, Gaffen SL (2019) The IL-17 family of cytokines in health and disease. Immunity 50(4):892\u2013906. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.021","journal-title":"Immunity"},{"issue":"3","key":"2846_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","volume":"131","author":"A Chiricozzi","year":"2011","unstructured":"Chiricozzi A, Guttman-Yassky E, Su\u00e1rez-Fari\u00f1as M, Nograles KE, Tian S, Cardinale I et al (2011) Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131(3):677\u2013687. https:\/\/doi.org\/10.1038\/jid.2010.340","journal-title":"J Invest Dermatol"},{"key":"2846_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184347","author":"K Kamiya","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M (2019) Risk factors for the development of psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20184347","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2846_CR11","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/bjd.12230","volume":"168","author":"K Danielsen","year":"2013","unstructured":"Danielsen K, Olsen AO, Wilsgaard T, Furberg AS (2013) Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol 168(6):1303\u20131310. https:\/\/doi.org\/10.1111\/bjd.12230","journal-title":"Br J Dermatol"},{"issue":"4","key":"2846_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","volume":"26","author":"E Christophers","year":"2001","unstructured":"Christophers E (2001) Psoriasis\u2013epidemiology and clinical spectrum. Clin Exp Dermatol 26(4):314\u2013320","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"2846_CR13","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","volume":"28","author":"CJL Murray","year":"2022","unstructured":"Murray CJL (2022) The global burden of disease study at 30 years. Nat Med 28(10):2019\u20132026. https:\/\/doi.org\/10.1038\/s41591-022-01990-1","journal-title":"Nat Med"},{"issue":"10258","key":"2846_CR14","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","journal-title":"Lancet"},{"issue":"10258","key":"2846_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0140-6736(20)31404-5","volume":"396","author":"GV Collaborators","year":"2020","unstructured":"Collaborators GV (2020) Five insights from the Global Burden of Disease Study 2019. Lancet 396(10258):1135\u20131159. https:\/\/doi.org\/10.1016\/S0140-6736(20)31404-5","journal-title":"Lancet"},{"issue":"12","key":"2846_CR16","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, Abdel-Rahman O et al (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749\u20131768. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996","journal-title":"JAMA Oncol"},{"issue":"10258","key":"2846_CR17","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1223\u20131249. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2","journal-title":"Lancet"},{"issue":"11","key":"2846_CR18","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF (2014) A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 23(11):2296\u20132302. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0300","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2846_CR19","unstructured":"Gupta PD (1993) Standardization and decomposition of rates: a users's manual, washington d"},{"issue":"13","key":"2846_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.028921","volume":"12","author":"R Ruan","year":"2023","unstructured":"Ruan R, Liu X, Zhang Y, Tang M, He B, Zhang Q-W et al (2023) Global, regional, and national advances toward the management of rheumatic heart disease based on the global burden of disease study 2019. J Am Heart Assoc 12(13):e028921. https:\/\/doi.org\/10.1161\/JAHA.122.028921","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"2846_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T et al (2018) Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 94(3):567\u2013581. https:\/\/doi.org\/10.1016\/j.kint.2018.04.011","journal-title":"Kidney Int"},{"key":"2846_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","volume":"369","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM (2020) National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 369:m1590. https:\/\/doi.org\/10.1136\/bmj.m1590","journal-title":"BMJ"},{"issue":"2","key":"2846_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/jid.2012.434","volume":"133","author":"M Enamandram","year":"2013","unstructured":"Enamandram M, Kimball AB (2013) Psoriasis epidemiology: the interplay of genes and the environment. J Invest Dermatol 133(2):287\u2013289. https:\/\/doi.org\/10.1038\/jid.2012.434","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2846_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","volume":"60","author":"SK Kurd","year":"2009","unstructured":"Kurd SK, Gelfand JM (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003\u20132004. J Am Acad Dermatol 60(2):218\u2013224. https:\/\/doi.org\/10.1016\/j.jaad.2008.09.022","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2846_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1468-3083.2012.04531.x","volume":"27","author":"XT Lima","year":"2013","unstructured":"Lima XT, Minnillo R, Spencer JM, Kimball AB (2013) Psoriasis prevalence among the 2009 AAD National Melanoma\/Skin Cancer Screening Program participants. J Eur Acad Dermatol Venereol 27(6):680\u2013685. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04531.x","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2846_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/rheumatology\/ker370","volume":"51","author":"R Li","year":"2012","unstructured":"Li R, Sun J, Ren L-M, Wang H-Y, Liu W-H, Zhang X-W et al (2012) Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford) 51(4):721\u2013729. https:\/\/doi.org\/10.1093\/rheumatology\/ker370","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2846_CR27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, Symmons DPM, Griffiths CEM, Ashcroft DM (2013) Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133(2):377\u2013385. https:\/\/doi.org\/10.1038\/jid.2012.339","journal-title":"J Invest Dermatol"},{"issue":"2","key":"2846_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/bjd.19169","volume":"184","author":"IYK Iskandar","year":"2021","unstructured":"Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM (2021) Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol 184(2):243\u2013258. https:\/\/doi.org\/10.1111\/bjd.19169","journal-title":"Br J Dermatol"},{"issue":"3","key":"2846_CR29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13(3):450\u2013456","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"2846_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/1346-8138.16856","volume":"50","author":"C Chen","year":"2023","unstructured":"Chen C, Che K, Guo Y, Huang Q, Hu X, Yu B (2023) Effect of the age of onset on epidemiology, clinical features, and comorbidity of geriatric psoriasis. J Dermatol 50(9):1156\u20131161. https:\/\/doi.org\/10.1111\/1346-8138.16856","journal-title":"J Dermatol"},{"issue":"1","key":"2846_CR31","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.1038\/s41467-022-34323-4","volume":"13","author":"MT Patrick","year":"2022","unstructured":"Patrick MT, Li Q, Wasikowski R, Mehta N, Gudjonsson JE, Elder JT et al (2022) Shared genetic risk factors and causal association between psoriasis and coronary artery disease. Nat Commun 13(1):6565. https:\/\/doi.org\/10.1038\/s41467-022-34323-4","journal-title":"Nat Commun"},{"issue":"6","key":"2846_CR32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/1346-8138.1584","volume":"48","author":"F Yamazaki","year":"2021","unstructured":"Yamazaki F (2021) Psoriasis: comorbidities. J Dermatol 48(6):732\u2013740. https:\/\/doi.org\/10.1111\/1346-8138.1584","journal-title":"J Dermatol"},{"key":"2846_CR33","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1038\/nrdp.2016.82","volume":"2","author":"JE Greb","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, Lebwohl MG, Gladman DD, Wu JJ et al (2016) Psoriasis. Nat Rev Dis Primers 2:16082. https:\/\/doi.org\/10.1038\/nrdp.2016.82","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2846_CR34","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","volume":"163","author":"K Abuabara","year":"2010","unstructured":"Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM (2010) Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 163(3):586\u2013592. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09941.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"2846_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","volume":"80","author":"SB Kaushik","year":"2019","unstructured":"Kaushik SB, Lebwohl MG (2019) Psoriasis: Which therapy for which patient: psoriasis comorbidities and preferred systemic agents. J Am Acad Dermatol 80(1):27\u201340. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.057","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2846_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.15021","volume":"176","author":"DA Springate","year":"2017","unstructured":"Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CEM, Ashcroft DM (2017) Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol 176(3):650\u2013658. https:\/\/doi.org\/10.1111\/bjd.15021","journal-title":"Br J Dermatol"},{"issue":"1","key":"2846_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota K, Kamijima Y, Sato T, Ooba N, Koide D, Iizuka H et al (2015) Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open 5(1):e006450. https:\/\/doi.org\/10.1136\/bmjopen-2014-006450","journal-title":"BMJ Open"},{"issue":"3","key":"2846_CR38","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","volume":"70","author":"TD Rachakonda","year":"2014","unstructured":"Rachakonda TD, Schupp CW, Armstrong AW (2014) Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 70(3):512\u2013516. https:\/\/doi.org\/10.1016\/j.jaad.2013.11.013","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02846-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T09:05:11Z","timestamp":1712653511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02846-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["2846"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02846-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study did not require informed consent as it did not involve human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"114"}}